Will science save us?
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Tuesday's elections continue to make headlines, but the big news at the end of the week was the announcement of a new antiviral treatment for COVID-19. According to Pfizer, which developed the drug, Paxlovid cuts the risk of hospitalization or death by 89 percent. The drug doesn't prevent infection, so it's not exactly a cure. Combined with vaccines, though, it could reduce the pandemic from a social crisis to a seasonal annoyance.
That's not the only good news from the scientific world. On Friday, The New York Times reported a Russian project that provides heat using a small, sea-borne nuclear reactor. Although there are genuine risks, nuclear energy is the most plausible low-emissions alternative to fossil fuel. That means it's an unavoidable part of any serious response to climate change.
Combined with other recent developments such as the malaria vaccine, these innovations encourage a certain optimism about the future. Despite fears of cultural decadence and technological stagnation, scientific research continues to generate new tools for addressing real problems.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Those tools aren't solutions. There will likely be other pandemics. And more widespread use of nuclear power won't stop climate change. But these developments are good reminders that technological ingenuity is not dead — and remains our best hope for coping with some of our own worst tendencies.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Samuel Goldman is a national correspondent at TheWeek.com. He is also an associate professor of political science at George Washington University, where he is executive director of the John L. Loeb, Jr. Institute for Religious Freedom and director of the Politics & Values Program. He received his Ph.D. from Harvard and was a postdoctoral fellow in Religion, Ethics, & Politics at Princeton University. His books include God's Country: Christian Zionism in America (University of Pennsylvania Press, 2018) and After Nationalism (University of Pennsylvania Press, 2021). In addition to academic research, Goldman's writing has appeared in The New York Times, The Wall Street Journal, and many other publications.
